Abstract
Background. Anemia and decreased testosterone levels in men are common comorbidities in immune-mediated inflammatory rheumatic diseases (IIRDs). Aim. To evaluate the relationship between total testosterone (TT) and hepcidin and erythropoietin levels in men with IIRDs and anemia. Materials and methods. A cross-sectional study included 136 men with IIRDs (66 patients with rheumatoid arthritis – RA, 44 with ankylosing spondylitis – AS, 26 with psoriatic arthritis – PsA) and anemia. A correlation analysis was performed for all quantitative parameters with TT, hepcidin, and erythropoietin levels, as well as a comparative subgroup analysis between patients with normal and reduced (≤12.0 nmol/L) TT. Results. In RA, AS and PsA and anemia, the subgroup with reduced TT was characterized by comparable levels of hemoglobin and erythropoietin compared to patients without androgen deficiency. The hepcidin level in RA patients with testosterone deficiency was significantly higher (38.0 [31.8; 39.1] ng/ml versus 21.5 [7.8; 30.5] ng/ml; p0.001) in RA patients. Among patients with AS, the subgroup with reduced TT was characterized by comparable levels of hepcidin (29.2 [6.5; 34.1] ng/ml versus 31.3 [27.2; 34.9] ng/ml; p=0.3). Among patients with PsA, the subgroup with reduced TT levels was characterized by higher hepcidin levels in testosterone deficiency (37.0 [29.9; 38.7] ng/ml vs. 25.8 [4.6; 33.0] ng/ml; p=0.009). Conclusion. The obtained results indicate no relationship between TT levels and erythropoietin in patients with RA, AS, and PsA and concomitant anemia, while reduced TT levels were associated with increased hepcidin levels in RA and PsA, and are most likely due to high IIRD activity.

This publication has 17 references indexed in Scilit: